Per Fischer1, Marcus Sagerfors2, Hugo Jakobsson2, Kurt Pettersson2. 1. Department of Hand Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. Electronic address: per.fischer@regionvarmland.se. 2. Department of Hand Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Abstract
PURPOSE: To assess long-term implant survival in total wrist arthroplasty (TWA), comparing 4 different implants. METHODS: In a prospective cohort of 124 patients, 136 TWAs were evaluated 5 years and 10 years after surgery. The TWAs were implanted between 2005 and 2009. The primary outcome was implant survival. Survival analysis was performed with revision and radiographic loosening as the final end point. Revision was defined as exchange of whole or parts of the prosthesis. Implant loosening was assessed using radiographic examination at the 5-year and 10-year follow-up. Secondary outcome measures included wrist range of motion, hand grip strength, visual analog scale (VAS) pain scores, and patient-related outcome measures, including Disabilities of the Arm, Shoulder, and Hand (DASH), Patient-Rated Wrist Evaluation (PRWE), and Canadian Occupational Performance Measure (COPM). RESULTS: Total cumulative implant survival was 92% with revision as the primary end point. When including a nonrevised radiographic loose implant as a failure, total implant survival was 75%. Radiographic loosening differed significantly between the implants with a range in frequency from 0% to 37.5%. At the 10-year follow-up, assessing the nonrevised TWAs, range of motion was preserved compared with preoperative values. Significant improvement was recorded for hand grip strength, VAS pain scores, and patient-related outcome measures at the 10-year follow-up compared with preovperative values. CONCLUSIONS: High 10-year implant survival was found when defining the primary end point as revision of any cause. When including radiographic loosening of the implant in the survival analysis, implant survival was considerably lower. However, radiographic loosening does not seem to correlate with changes in secondary outcome measures, questioning the need for revision surgery in these cases. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.
PURPOSE: To assess long-term implant survival in total wrist arthroplasty (TWA), comparing 4 different implants. METHODS: In a prospective cohort of 124 patients, 136 TWAs were evaluated 5 years and 10 years after surgery. The TWAs were implanted between 2005 and 2009. The primary outcome was implant survival. Survival analysis was performed with revision and radiographic loosening as the final end point. Revision was defined as exchange of whole or parts of the prosthesis. Implant loosening was assessed using radiographic examination at the 5-year and 10-year follow-up. Secondary outcome measures included wrist range of motion, hand grip strength, visual analog scale (VAS) pain scores, and patient-related outcome measures, including Disabilities of the Arm, Shoulder, and Hand (DASH), Patient-Rated Wrist Evaluation (PRWE), and Canadian Occupational Performance Measure (COPM). RESULTS: Total cumulative implant survival was 92% with revision as the primary end point. When including a nonrevised radiographic loose implant as a failure, total implant survival was 75%. Radiographic loosening differed significantly between the implants with a range in frequency from 0% to 37.5%. At the 10-year follow-up, assessing the nonrevised TWAs, range of motion was preserved compared with preoperative values. Significant improvement was recorded for hand grip strength, VAS pain scores, and patient-related outcome measures at the 10-year follow-up compared with preovperative values. CONCLUSIONS: High 10-year implant survival was found when defining the primary end point as revision of any cause. When including radiographic loosening of the implant in the survival analysis, implant survival was considerably lower. However, radiographic loosening does not seem to correlate with changes in secondary outcome measures, questioning the need for revision surgery in these cases. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.
Authors: Mario Igor Rossello; Irene Zotta; Carlo Rossello; Matteo Formica; Andrea Zoccolan Journal: Indian J Orthop Date: 2022-04-22 Impact factor: 1.033
Authors: Bardiya Akhbari; Amy M Morton; Kalpit N Shah; Janine Molino; Douglas C Moore; Arnold-Peter C Weiss; Scott W Wolfe; Joseph J Crisco Journal: J Biomech Date: 2021-04-15 Impact factor: 2.789
Authors: Christoph Biehl; Martin Stoll; Martin Heinrich; Lotta Biehl; Jochen Jung; Christian Heiss; Gabor Szalay Journal: Life (Basel) Date: 2021-04-18
Authors: Jörg Eschweiler; Jianzhang Li; Valentin Quack; Björn Rath; Alice Baroncini; Frank Hildebrand; Filippo Migliorini Journal: Life (Basel) Date: 2022-03-11